Organovo Holdings Inc
NASDAQ:ONVO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Organovo Holdings Inc
NASDAQ:ONVO
|
US |
Balance Sheet
Balance Sheet Decomposition
Organovo Holdings Inc
Organovo Holdings Inc
Balance Sheet
Organovo Holdings Inc
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
50
|
62
|
63
|
44
|
36
|
27
|
37
|
29
|
15
|
3
|
|
| Cash Equivalents |
50
|
62
|
63
|
44
|
36
|
27
|
37
|
29
|
15
|
3
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Receivables |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
51
|
64
|
65
|
47
|
39
|
28
|
38
|
30
|
17
|
4
|
|
| PP&E Net |
2
|
4
|
4
|
3
|
2
|
0
|
0
|
3
|
3
|
2
|
|
| PP&E Gross |
2
|
4
|
4
|
3
|
2
|
0
|
0
|
3
|
3
|
2
|
|
| Accumulated Depreciation |
1
|
2
|
3
|
4
|
5
|
0
|
1
|
1
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Total Assets |
53
N/A
|
68
+26%
|
69
+2%
|
50
-28%
|
41
-18%
|
28
-30%
|
40
+40%
|
33
-17%
|
20
-39%
|
6
-69%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
|
| Accrued Liabilities |
3
|
3
|
4
|
4
|
3
|
1
|
0
|
1
|
3
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
5
|
4
|
6
|
5
|
4
|
2
|
1
|
1
|
4
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
1
|
1
|
1
|
1
|
0
|
0
|
2
|
1
|
1
|
|
| Total Liabilities |
5
N/A
|
5
+13%
|
7
+26%
|
5
-23%
|
4
-17%
|
2
-58%
|
1
-60%
|
3
+329%
|
5
+61%
|
3
-45%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
122
|
161
|
199
|
234
|
261
|
279
|
296
|
308
|
325
|
340
|
|
| Additional Paid In Capital |
171
|
223
|
262
|
279
|
297
|
306
|
335
|
338
|
340
|
343
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
49
N/A
|
62
+28%
|
62
+0%
|
45
-28%
|
36
-19%
|
27
-27%
|
39
+47%
|
30
-23%
|
15
-49%
|
4
-77%
|
|
| Total Liabilities & Equity |
53
N/A
|
68
+26%
|
69
+2%
|
50
-28%
|
41
-18%
|
28
-30%
|
40
+40%
|
33
-17%
|
20
-39%
|
6
-69%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
4
|
5
|
5
|
6
|
6
|
7
|
9
|
9
|
9
|
10
|
|